Administration of the GnRH antagonist cetrorelix during the luteal phase of the mare

Theriogenology

Volumn 58, Issue 2-4, 2002, Pages 527-532

  Evans, Margaret J ^a   Alexander, S L ^a   Irvine, C H G ^b   Taylor, T B ^c   Kitson, N E ^a   Livesey, J H ^a  

^a CHRISTCHURCH HOSPITAL   (New Zealand)

^b LINCOLN UNIVERSITY   (New Zealand)

^c Veterinary Clinic   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

CETRORELIX; GONADORELIN; GONADORELIN ANTAGONIST;

ADOLESCENT; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; FOLLITROPIN BLOOD LEVEL; FOLLITROPIN RELEASE; HORMONE ACTION; HORMONE INHIBITION; HORSE; LUTEAL PHASE; LUTEINIZING HORMONE BLOOD LEVEL; NONHUMAN; OVARY FOLLICLE DEVELOPMENT;

EQUUS CABALLUS;

EID: 0036341549     PISSN: 0093691X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0093-691X(02)00780-X     Document Type: Article

References (7)

1. Serum concentrations of FSH, LH and progesterone during the oestrous cycle and early pregnancy in the mare
2. Gonadotrophin profiles and dioestrus pulsatile release patterns in mares as determined by collection of jugular blood at 4 h intervals throughout an oestrous cycle
3. Growth of small follicles and concentrations of FSH during the equine oestrous cycle
4. Gonadotrophin responses to GnRH can be blocked by the antagonist cetrorelix given to mares
5. New antagonists of LHRH II. Inhibition and potentiation of LHRH by closely related analogues
6. Reproductive hormone profiles in mares during the autumn transition as determined by collection of jugular blood at 6 h intervals throughout the ovulatory and anovulatory cycles
7. Control of follicular development and luteal function in the mare: Effects of a GnRH antagonist